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SOFAAbstract Background: Scoring systems can be used to deﬁne critically ill patients, estimate their
prognosis, help in clinical decision making, guide the allocation of resources and estimate the qual-
ity of care in the ICU.
Purpose: This study compared the predictive accuracy of four predictive scoring systems in the
ICU.
Methods: A prospective cohort study including consecutively admitted 110 adult ICU patients
(88 males) with ARDS from Saudi German Hospital, Madinah, was performed from June 2013
to January 2015. The median age of the patients was 38 years, the median duration of illness before
ICU admission was 6 days, and the median duration of ICU admission was 27 days. The APACHE
II, APACHE III, SAPS II, and SOFA scores were calculated based on the worst values during the
ﬁrst 24 h of admission.
Results: The actual mortality rate (27.3%) was higher than the estimated mortality rates, with
the highest predicted rate of 11.3% obtained using the APACHE II. All four severity scores were
signiﬁcantly associated with mortality (F= 62.772, p= 0.000) and explained 83% of its variability
(R2 = 0.834). However, after adjustment, only the APACHE III scoring system was a signiﬁcant
predictor (Beta = 0.753, p= 0.000). Three scoring systems were signiﬁcantly associated with
mortality (F= 42.055, p= 0.000) and explained almost 70% of its variability (R2 = 0.712), but
after adjustment, only the APACHE II was a signiﬁcant predictor (Beta = 0.631, p= 0.041).rculosis.
844 A. Saleh et al.The combination of the severity score and mortality prediction was a signiﬁcant predictor of mor-
tality (Beta = 1.397, p= 0.000 and Beta = 0.517, p= 0.036, respectively).
Conclusion: The accuracy of the studied scoring systems for predicting ICU mortality in ARDS
patients is limited. The performance of the APACHE II/III scoring systems was superior to that of
other systems in terms of predicting the severity and mortality, and the combination of scores
improved the performance. There is a need to develop ARDS-speciﬁc scoring systems. Until a
new system is developed, it is better to use the updated versions of the APACHE scoring system
or a combination of all ICU scoring systems.
ª 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of The Egyptian Society of Chest
Diseases and Tuberculosis. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Clinical assessment of the severity of illness is an essential com-
ponent of medical practice to predict the mortality and mor-
bidity of critically ill patients, especially in the intensive care
unit (ICU) [1,2]. Physiologically based scoring systems are
more applicable than diagnosis-based scoring systems and
can estimate the risk based on the degree of variation from
the normal function of major organ systems [1,2]. Acute respi-
ratory distress syndrome (ARDS) is among the leading causes
of mortality in critically ill patients. ARDS is an acute, diffuse,
inﬂammatory lung injury, leading to increased pulmonary vas-
cular permeability, increased lung weight, and a loss of aerated
lung tissue. The clinical hallmarks of ARDS are hypoxemia
and bilateral radiographic opacities, while the pathological
hallmark is diffuse alveolar damage [3].
The Acute Physiology And Chronic Health Evaluation
(APACHE), introduced in 1981, takes into consideration var-
ious parameters, such as physiological variables, vital signs,
urine output, the neurological score, age and co-morbid condi-
tions, which may have a signiﬁcant impact on the outcome of
critically ill patients [4]. The APACHE II, formulated in 1985,
estimates the risk based on the worst variables available within
the ﬁrst 24 h of admission. The APACHE II is widely used to
quantify the severity of illness in the ICU, and has been vali-
dated in many clinical trials. The APACHE III scoring system
is similar to the APACHE II system, except that several vari-
ables have been added (e.g., diagnosis, prior treatment loca-
tion) [5].
The Simpliﬁed Acute Physiology Score (SAPS) streamlines
data collection and analysis without compromising the diag-
nostic accuracy. The SAPS II is the most widely used version.
It calculates a severity score using the worst values measured
during the initial 24 h in the ICU for 17 variables [6]. The
Sequential Organ Failure Assessment (SOFA) uses simple
measurements of major organ functions to calculate a severity
score. The scores are calculated 24 h after admission to the
ICU and every 48 h thereafter. The mean and the highest
scores are most predictive of mortality. In addition, scores that
increase by approximately 30% are associated with a mortality
rate of at least 50% [7]. The original SOFA instrument was
derived from a cohort of 1449 patients admitted to 40 ICUs
in 16 countries [8].
There have been no large, prospective studies that have
compared the different ICU predictive scoring systems in a
subset of patients with ARDS. A systemic review of the
SOFA, SAPS II, APACHE II, and APACHE III scoring sys-
tems found that the APACHE systems were slightly superiorto the SAPS II and SOFA systems in predicting ICU mortality
[9]. In a previous study, the accuracy of both the SAPS II and
APACHE instruments improved when combined with the
assessment of sequential SOFA scores.
Four predictive scoring systems were evaluated in the pre-
sent study to determine, which system is the best for predicting
the outcomes of ARDS patients. These were the Acute
Physiology and Chronic Health Evaluation (APACHE) sys-
tems II and III, the Simpliﬁed Acute Physiology Score II
(SAPS II), and the Sequential Organ Failure Assessment score
(SOFA). According to a Medline search, no study comparing
these four scoring systems had been reported in our region
(Middle East). Thus, we designed this study to compare the
performance of the four scoring systems in ARDS patients.
Subjects and methods
This prospective cohort study was conducted in the Adult ICU
at the Saudi German Hospital Al-Madinah, KSA. One hun-
dred and ten consecutively admitted adult patients admitted
between June 2013 and January 2015 were included in the
study after obtaining consent from the institutional review
board. The consent for participation was obtained at time of
admission from the patients themselves or from the relatives
who were most acquainted with the patient; a waiver of
informed consent was granted by the IRB due to the minimal
risk of the observational study.
The diagnostic evaluation was performed on admission to
exclude other differential diagnoses and to identify the speciﬁc
causes of ARDS. We included patients who met the 2012
Berlin deﬁnition criteria for ARDS [10].
The exclusion criteria included acute interstitial pneumonia
(Hamman–Rich syndrome), disseminated cancer, eosinophilic
pneumonia, diffuse alveolar hemorrhage associated with colla-
gen vascular diseases, and cardiogenic pulmonary edema.
Patients were also excluded if they refused to participate, died
within 24 h of the ARDS diagnosis, or when the diagnosis of
ARDS or other alternative causes of acute hypoxemic respira-
tory failure could not be established based on the clinical con-
text, symptoms, signs, and bronchoscopy in patients whose
acute hypoxemic respiratory failure remained of uncertain etiol-
ogy after non-diagnostic ﬂexible bronchoscopy if one or more of
the diagnostic possibilities under consideration might warrant
targeted therapy or would substantially change the prognosis.
Scoring systems: The APACHE II, APACHE III, SAPS II,
and SOFA scores were calculated based on the worst values
recorded during the ﬁrst 24 h of admission. All enrolled
patients were followed during their ICU stay, and the outcome
Figure 1 Results of linear regression analysis of the mortality
prediction of the individual and combined ICU scoring systems
(APACHE III, APACHE II, SAPS II, and SOFA) in ARDS
patients. p= 0.036.
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identiﬁed patients, the institutional APACHE III database
was searched using the software program provided by Cerner
Corporation (Kansas City, Missouri), and APACHE III data
were abstracted. The online combination ICU Mortality
Calculator (APACHE II, SAPS II, and SOFA scores to pre-
dict hospital mortality; http://clincalc.com/IcuMortality/
Default.aspx) was used to calculate the corresponding score
for each patient. The data included age, gender, vital signs,
Glasgow Coma Scale scores, and urine output, which were
abstracted at the bedside by trained nurses according to a for-
malized protocol, and which were entered into the computer
by trained specialists. The APACHE III system score was cal-
culated separately using the http://www.quesgen.com/
ApacheIII.php database.
Statistical analysis
The data analysis was performed using the Statistical Package
for the Social Sciences software program version 20 (SPSS
Inc., Chicago, IL). Descriptive data were expressed as mediansTable 1 Characteristic data, ICU scoring systems of severity and e
Gender: n (%) Females: n (%)
Males: n (%)
Age: years
Duration of illness before ICU admission: days
Duration of ICU admission: days
APACHE II Severity score
Estimated mortality: %
SAPS II Severity score
Estimated mortality: %
SOFA Severity score
Estimated mortality: %
APACHE III Severity score
Combined scoring systems Severity score
Estimated mortality: %
Mortality Died: n (%)
Survived: n (%)(due to their abnormal distribution) or percentages. The statis-
tical analysis was performed using non-parametric statistics to
compare the two mortality groups (survivors/non-survivors).
A linear regression analysis was performed, and Microsoft
Excel was used to generate Fig. 1. The statistical tests were
two-tailed and a value of p< 0.05 was considered to be the
cut-off value of signiﬁcance.Results
This study included 22 females (20%) and 88 males (80%),
with a median age of 38 years (26–84 years), who had a median
duration of illness before ICU admission of 6 (2–15) days
(Table 1). After being monitored for a median period of 27
(8–45) days, 30 of the patients died (mortality rate: 27.3%;
Table 1). However, the predicted mortality rates were lower
than the actual mortality rate, with the highest rate of 11.3%
calculated using the APACHE II and the lowest rates calcu-
lated with the SAPS (7.9%) and SOFA (<10%) scoring
systems.
A comparison of the different ICU scoring systems for the
disease severity and estimated mortality in ARDS patients
(Table 2) showed that all four ICU scoring systems had statis-
tically signiﬁcant differences between survivors and non-
survivors.
The multivariate regression showed that the four different
scores were all signiﬁcantly associated with mortality
(F= 131.82, p= 0.000), and explained 83% of its variability
(R2 = 0.834). However, after adjustment, only the APACHE
III scoring system was a signiﬁcant predictor of mortality
(Beta = 0.753, p= 0.000). Three different methods signiﬁ-
cantly estimated the mortality (F= 42.055, p= 0.000) and
explained almost 70% of its variability (R2 = 0.712).
However, after adjustment, only the APACHE II was a signif-
icant predictor of mortality (Beta = 0.631, p= 0.041). The
combination of the severity score and mortality prediction
was a signiﬁcant predictor of mortality (Beta = 1.397,
p= 0.000 and Beta = 0.517, p= 0.036, respectively) (Fig. 1).stimated mortality, and mortality in ARDS patients.
Median Minimum Maximum
22 (20)
88 (80)
38 26 84
6 2 15
27 8 45
10 5.00 34.00
11.3 5.8 81
26 16.00 75.00
7.9 2.30 88.90
4 2 11
<10 <10 40–50
53 29.00 112.00
22 16.25 54.75
8.9 5.7 63.13
30 (27.3)
80 (72.7)
Table 2 Comparison of different ICU scoring systems of severity and estimated mortality in ARDS patients.
Survivors n= 80 Non-survivors n= 30 p
APACHE II Score (median) 8 27 0.000
Estimated mortality (%) 8.7 60.5 0.000
SAPS II Score (median) 21 60 0.000
Estimated mortality (%) 4.2 68.10 0.000
SOFA Score (median) 4 9 0.000
Estimated mortality (%) <10 10–20 0.000
APACHE III Score (median) 43 96 0.000
Combined scoring systems Score (median) 19.88 49.25 0.000
Estimated mortality (%) 8.17 47.43 0.000
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ARDS is among the main causes of mortality in critically ill
patients [3]. The mortality rate in this study (27.3%) was lower
than the previously reported estimates ranging from 26% to
58% [11–13]. This agrees with other studies which found better
survival rates over time [14–16]. However, the mortality rate in
this study was higher than that predicted by different scoring
systems. The Severity scores and mortality prediction in ICU
patients are important for facilitating the management of hos-
pital resources [17], evaluating the quality of care [18–20], and
most importantly evaluating therapeutic interventions [21],
especially for patients with ARDS [22,23].
As observed in other studies [24,25], our survivors had sig-
niﬁcantly lower median scores for all scoring systems com-
pared to non-survivors (Table 2).
Moreover, linear regression analysis conﬁrmed an indepen-
dent association between the severity scores and mortality pre-
diction by different scoring systems and mortality.
Our present results showed that the only signiﬁcant predic-
tors of mortality were the APACHE II and III and the com-
bined score of the four systems (Fig. 1). The APACHE II
score in this study ranged from 5 to 34, with a median of 10.
These results agree with those described by Parajuli et al. in
2015 [26] who reported a range of 6–35, with a mean score
of 18.26 ± 7.40. Moreover this range is comparable to that
reported from other areas of the world, including India [27],
Bangladesh [28] and Turkey [29].
The APACHE III system is similar to APACHE II system
[30] but with more data and daily updates of the clinical infor-
mation used to recalculate the estimated mortality [30]. It is
expected that APACHE III mortality prediction will be more
accurate than a single projection based upon the ﬁrst 24 h of
ICU admission [31]. Unfortunately, the mortality prediction
by this score was not included in this study due to the use of
the initial 24 h data by other scoring systems, which could have
interfered with comparisons between different scoring systems.
The combined score of the four systems improved the mortal-
ity prediction. Since different scoring systems have different
aims and measurements, they should be combined, rather than
competing against each other [32].
In this study, only the APACHE II gave a mortality predic-
tion >10%, while the other scoring systems gave a mortality
prediction <10%. The three scoring systems and their com-
bined scores underestimated the actual mortality in ICUpatients. In the Escarce et al. study [24], the calculated
APACHE II score underestimated the predicted mortality
risks for patients who were transferred from different settings
(hospital ﬂoors: 38% vs 55%, intermediate care unit: 32% vs
59%, and other hospitals: 21% vs 36%) but was close to the
actual rate for patients who were admitted directly from the
emergency department (25% vs 22%).
Another study [25] validated SAPS II and APACHE II and
found that the observed mortality of high risk mainly surgical
patients (above 60%) was over-predicted by SAPS II and
under-predicted by APACHE II. The same study also found
that the actual mortality was signiﬁcantly higher than that pre-
dicted by any of the 2 scores. Another study of patients from
Scottish ICUs [19] compared 6 scoring systems and found sig-
niﬁcantly different observed mortalities from those predicted
with the best overall performance by SAPS II and better cali-
bration by APACHE II.
The difference between the predicted and actual mortality
rates may be explained by the limited accuracy of the mortality
prediction models because they are limited by the items
included, and subjected to interpretation and inﬂuenced by
many factors including local admission, discharge and man-
agement policies [32]. They are likely to under- or over-
estimate mortality in selected patient subpopulations because
the original cohort was mixed. Another explanation is that
the single performance of these scoring systems during the ini-
tial 24 h as predictive models requires periodic retesting, revis-
ing, and updating, because its accuracy decreases as treatments
and other factors inﬂuencing the mortality rate change.
The main strength of this study is the inclusion of a subpop-
ulation of ICU patients for accuracy of mortality prediction by
otherwise non-speciﬁc scoring systems. However, the study
was limited by its small size. Another limitation is the non-
inclusion of the updated versions of some of the scoring sys-
tems, such as the APACHE IV, SAPS III, and the Mortality
Prediction Model (MPM), in this comparative study.
Conclusion
The four studied ICU predictive scoring systems (APACHE II,
APACHE III, SAPS II, and SOFA) gave signiﬁcantly different
severity scores and mortality prediction in survivors compared
to non-survivors among ICU patients with ARDS. However,
their accuracy in predicting the actual mortality was limited.
The performance of the APACHE II/III scoring systems was
Accuracy of scoring systems in ARDS 847superior to that of the other systems in mortality prediction,
and applying a combination of scoring systems improved the
performance.
Recommendation
There is a need to develop an ARDS-speciﬁc scoring system
for better severity grading and mortality prediction. Until such
a system is developed, it is better to use the updated versions of
the APACHE scoring system including daily updates or a
combination of the available ICU scoring systems. To improve
the predictions, it is necessary to update the APACHE III
score daily. At present, it is recommended that the APACHE
scoring system (APACHE IV if available) be used rather than
other systems for predicting the mortality because of its supe-
rior accuracy. It is recommended that clinicians use the most
recent version of the APACHE scoring system because it
includes frequent daily updates to the data.
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